Search results for "Parkinson's disease"
DTC screening tests a source of concern
With the proliferation of the number and scope of direct-to-consumer tests, ACP is concerned about the unnecessary costs and undue anxiety for patients when results lead to follow-up testing to rule out a medical concern.
https://immattersacp.org/archives/2018/06/dtc-screening-tests-a-source-of-concern.htm
1 Jun 2018
‘New narrative’ for back pain means managing modalities
New modalities to treat low back pain can include alternative treatments like mindfulness meditation, acupuncture, mindful stress reduction, tai chi, yoga, and cognitive behavioral therapy.
https://immattersacp.org/archives/2018/05/new-narrative-for-back-pain-means-managing-modalities.htm
1 May 2018
Bringing medicine back to the bedside
The physical exam itself is widely considered to be underutilized, but many of the country's medical educators and master clinicians are determined to bring it back to prominence.
https://immattersacp.org/archives/2018/02/bringing-medicine-back-to-the-bedside.htm
1 Feb 2018
Early oral anticoagulation in afib may protect against dementia
Taking anticoagulant treatment at baseline was associated with a 29% lower risk of dementia than not receiving anticoagulant treatment and a 48% lower risk when analyzed on treatment.
https://immattersacp.org/weekly/archives/2017/10/31/1.htm
31 Oct 2017
Warning on IBS drug for patients without gallbladders
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/05/fda.htm
1 May 2017
Digging into the causes and fixes of resistant hypertension
An enduring challenge is figuring out why patients appear to have resistant hypertension and how to cure them of it.
https://immattersacp.org/archives/2016/09/hypertension.htm
1 Sep 2016
Warning on an antipsychotic; generic rosuvastatin approval
This update covers a warning that aripiprazole may be associated with compulsive or uncontrollable urges, as well as approval of the first generic version of rosuvastatin tablets.
https://immattersacp.org/archives/2016/07/fda.htm
1 Jul 2016
Keys to taking a neurological history
The most powerful tool in neurology is the history and physical exam, including the requirement that patients walk in the presence of neurologists, in order to better understand symptoms.
https://immattersacp.org/archives/2016/07/neurology.htm
1 Jul 2016
Warning on an antipsychotic; generic rosuvastatin approval
This update covers new warnings on the entire class of opioids and approval of the first leadless pacemaker approved to treat heart rhythm disorders.
https://immattersacp.org/archives/2016/06/fda.htm
1 Jun 2016
Warning on HCV treatments; more cancer drugs approved
This update also covers a warning that combination drugs can cause serious liver injury and approval of new drugs for metastatic non-small-cell lung cancer that has progressed after other treatments.
https://immattersacp.org/archives/2016/01/fda.htm
1 Jan 2016